P. McIntyre

发表

Corticosteroids for acute bacterial meningitis.

M. Brouwer, D. van de Beek, P. McIntyre, 2015, The Cochrane database of systematic reviews.

Using computer simulations to compare pertussis vaccination strategies in Australia.

Peter McIntyre, P. Horby, H. Hethcote, 2004, Vaccine.

Management of children with otitis media: A summary of evidence from recent systematic reviews

Peter McIntyre, Jonathan C Craig, P. Morris, 2009, Journal of paediatrics and child health.

Sources of pertussis infection in young infants: a review of key evidence informing targeting of the cocoon strategy.

K. Macartney, P. McIntyre, K. Wiley, 2013, Vaccine.

MODERN TRENDS IN MORTALITY FROM MENINGOCOCCAL DISEASE IN AUSTRALIA

N. Wood, R. Booy, P. McIntyre, 2009, The Pediatric infectious disease journal.

Predictors of Pneumococcal Vaccination Uptake in Hospitalized Patients Aged 65 Years and Over Shortly Following the Commencement of a Publicly Funded National Pneumococcal Vaccination Program in Australia

R. Lindley, R. MacIntyre, P. McIntyre, 2007, Human vaccines.

Systematic review of reporting rates of adverse events following immunization: an international comparison of post-marketing surveillance programs with reference to China.

Andrew Page, Richard J. K. Taylor, Peter McIntyre, 2013, Vaccine.

Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia.

Katherine J. Lee, J. Carlin, J. Bines, 2011, Vaccine.

Epidemiology and prevention of pneumococcal disease.

P. McIntyre, Peter Mcintyre, J. Carnie, 1997, Communicable diseases intelligence.

SPECTRUM AND MANAGEMENT OF OTITIS MEDIA IN AUSTRALIAN INDIGENOUS AND NON-INDIGENOUS CHILDREN: A NATIONAL STUDY

P. Morris, H. Britt, J. Craig, 2007, Pediatrics.

Australian vaccine preventable disease epidemiological review series: Pertussis, 2013-2018.

R. Lucas, A. Dey, H. Quinn, 2022, Communicable diseases intelligence.

Recent increases in mumps incidence in Australia: the “forgotten” age group in the 1998 Australian Measles Control Campaign

H. Quinn, P. McIntyre, G. Gilbert, 2008, The Medical journal of Australia.

Australia's notifiable diseases status, 1997. Annual report of the National Notifiable Diseases Surveillance System.

S. Torvaldsen, N. Gilroy, P. McIntyre, 1999, Communicable diseases intelligence.

Surveillance of adverse events following immunisation: Australia, 2000-2002.

D. Isaacs, N. Wood, P. Purcell, 2003, Communicable diseases intelligence quarterly report.

Parental Tdap Boosters and Infant Pertussis: A Case-Control Study

H. Quinn, P. McIntyre, T. Snelling, 2014, Pediatrics.

Rapid Increase in Pertactin-deficient Bordetella pertussis Isolates, Australia

V. Sintchenko, H. Marshall, C. Lam, 2014, Emerging infectious diseases.

Antibody and Cell-mediated Immunity to Pertussis 4 Years After Monovalent Acellular Pertussis Vaccine at Birth

P. Holt, H. Marshall, N. Wood, 2014, The Pediatric infectious disease journal.

Pertactin negative Bordetella pertussis demonstrates higher fitness under vaccine selection pressure in a mixed infection model.

V. Sintchenko, H. Marshall, C. Tay, 2015, Vaccine.

The relationship between Bordetella pertussis genotype and clinical severity in Australian children with pertussis.

V. Sintchenko, H. Marshall, S. Octavia, 2016, The Journal of infection.

Current developments in varicella-zoster virus disease prevention. A report on the varicella-zoster virus workshop convened by the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases on 16-17 November 2006.

C. Macintyre, A. Heywood, K. Macartney, 2007, Communicable diseases intelligence quarterly report.

Varicella vaccination in Australia

P. Beutels, K. Macartney, P. McIntyre, 2005, Journal of paediatrics and child health.

Vaccine-preventable diseases and vaccination coverage in Australia, 1999-2000.

P. Horby, B. Hull, P. McIntyre, 2002, New South Wales public health bulletin.

Vaccine preventable diseases and vaccination coverage in Australia, 1999 to 2000 This report was written at the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS) by:

P. Horby, B. Hull, P. McIntyre, 2002 .

Vaccine preventable diseases and vaccination coverage in Australia, 1999 to 2000.

P. Horby, B. Hull, P. McIntyre, 2002, Communicable diseases intelligence quarterly report.

When science is not enough – a risk/benefit profile of thiomersal-containing vaccines

P. McIntyre, C. J. Clements, Peter B. McIntyre, 2006, Expert opinion on drug safety.

Immunisation coverage in Australian children: a systematic review 1990-1998.

P. McIntyre, E. O'Brien, S. Lister, 1999, Communicable diseases intelligence.

Effectiveness of the linkage of child care and maternity payments to childhood immunisation.

B. Hull, P. McIntyre, G. Lawrence, 2004, Vaccine.

Corticosteroids for acute bacterial meningitis.

M. Brouwer, D. van de Beek, P. McIntyre, 2010, The Cochrane database of systematic reviews.

Cochrane review: Corticosteroids for acute bacterial meningitis

D. Beek, P. McIntyre, K. Prasad, 2008 .

Childhood asthma diagnosis and use of asthma medication.

J. Peat, P. McIntyre, C. MacIntyre, 2005, Australian family physician.

Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology

S. Lambert, P. McIntyre, K. Grimwood, 2014, Expert review of vaccines.

Estimating the measles effective reproduction number in Australia from routine notification data.

A. Dey, J. Wood, S. Davis, 2014, Bulletin of the World Health Organization.

Beyond expectations: Post-implementation data shows rotavirus vaccination is likely cost-saving in Australia.

P. Beutels, J. Wood, A. Newall, 2017, Vaccine.

State-of-the-art in the pneumococcal field: Proceedings of the 11th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD-11)

S. Madhi, W. Hanage, C. Whitney, 2020, Pneumonia.

Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine.

D. Descamps, P. McIntyre, T. Nolan, 2002, Vaccine.

Australia's notifiable diseases status, 2006: annual report of the National Notifiable Diseases Surveillance System.

R. Owen, P. McIntyre, D. Coleman, 2008, Communicable diseases intelligence quarterly report.

Implementation of mandatory immunisation of healthcare workers: observations from New South Wales, Australia.

C. Helms, J. Leask, P. McIntyre, 2011, Vaccine.

Steroids in adults with acute bacterial meningitis: a systematic review.

D. van de Beek, P. McIntyre, K. Prasad, 2004, The Lancet. Infectious diseases.

Influenza vaccines in healthy children

D. Isaacs, P. McIntyre, 2005, The Lancet.

Retrospective economic evaluation of childhood 7-valent pneumococcal conjugate vaccination in Australia: Uncertain herd impact on pneumonia critical.

P. Beutels, P. Beutels, J. Wood, 2016, Vaccine.

Varicella and herpes zoster hospitalizations before and after implementation of one-dose varicella vaccination in Australia: an ecological study.

A. Heywood, K. Macartney, P. McIntyre, 2014, Bulletin of the World Health Organization.

Bacterial Meningitis 3 Eff ect of vaccines on bacterial meningitis worldwide

B. Greenwood, D. Beek, P. McIntyre, 2012 .

Estimates of chronic hepatitis B virus infection in the Northern Territory.

N. Wood, P. McIntyre, H. Gidding, 2005, Communicable diseases intelligence quarterly report.

The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in Australia.

G. Gilbert, H. Quinn, P. McIntyre, 2007, Vaccine.

The end of the Australia antigen? An ecological study of the impact of universal newborn hepatitis B vaccination two decades on.

Bette C Liu, J. Kaldor, N. Wood, 2012, Vaccine.

Human papillomavirus prevalence to age 60 years among Australian women prevaccination.

S. Garland, J. Condon, S. Tabrizi, 2015, Sexual health.

Paediatric Active Enhanced Disease Surveillance: A new surveillance system for Australia

Y. Zurynski, E. Elliott, R. Booy, 2013, Journal of paediatrics and child health.

An evaluation of the Australian National Serosurveillance Program.

S. Deeks, P. McIntyre, R. Menzies, 2010, Communicable diseases intelligence quarterly report.

Rotavirus surveillance in Australia.

P. McIntyre, V. Krause, K. Ward, 2008, Communicable diseases intelligence quarterly report.

The impact of adolescent pertussis immunization, 2004-2009: lessons from Australia.

H. Quinn, P. McIntyre, 2011, Bulletin of the World Health Organization.

Using the Australian Childhood Immunisation Register to track the transition from whole-cell to acellular pertussis vaccines.

B. Hull, S. Torvaldsen, P. McIntyre, 2002, Communicable diseases intelligence quarterly report.

Reduction in Hospitalizations for Pneumonia Associated With the Introduction of a Pneumococcal Conjugate Vaccination Schedule Without a Booster Dose in Australia

P. McIntyre, R. Menzies, A. Jardine, 2010, The Pediatric infectious disease journal.

Australian vaccine preventable disease epidemiological review series: pertussis, 2006-2012.

H. Quinn, Alexis J Pillsbury, P. McIntyre, 2015, Communicable diseases intelligence quarterly report.

Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia, 1999 to 2002.

P. McIntyre, R. Menzies, F. Beard, 2004, Communicable diseases intelligence quarterly report.

Vaccine preventable diseases and vaccination coverage of Indigenous people Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islanders people , Australia , 1999 to 2002

P. McIntyre, R. Menzies, F. Beard, 2004 .

Duration of Protection After First Dose of Acellular Pertussis Vaccine in Infants

H. Quinn, K. Macartney, P. McIntyre, 2014, Pediatrics.

Tetanus in the elderly--An important preventable disease in Australia.

H. Quinn, P. McIntyre, 2007, Vaccine.

Has pertussis increased in NSW over the past decade? An evaluation using hospitalisation and mortality data versus notifications 1988-2002.

P. McIntyre, R. Menzies, Han Wang, 2003, New South Wales public health bulletin.

Infant, maternal and demographic predictors of delayed vaccination: A population-based cohort study.

Bette C Liu, K. Edmond, L. Jorm, 2020, Vaccine.

Effect of vaccines on bacterial meningitis worldwide

K. O'Brien, B. Greenwood, D. Beek, 2012, The Lancet.

Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program.

Katherine J. Lee, J. Carlin, J. Bines, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of the introduction of rotavirus vaccine on the timeliness of other scheduled vaccines: the Australian experience.

B. Hull, K. Macartney, P. McIntyre, 2013, Vaccine.

Vaccine preventable diseases in indigenous populations - International perspectives. Satellite Symposium of the 5th International Symposium on Pneumococci and Pneumococcal Diseases, April 2006, Alice Springs, Australia.

Leo F. Nolan, K. O'Brien, A. Leach, 2007, Vaccine.

Refusal of parents to vaccinate: dereliction of duty or legitimate personal choice?

P. McIntyre, A.H. Williams, Julie E Leask, 2003, The Medical journal of Australia.

Factors influencing vaccination uptake. Workshop report. Current Australian research on the behavioural, social and demographic factors influencing immunisation, Royal Alexandra Hospital for Children, Sydney, March 1998.

P. McIntyre, M. Burgess, J. Forrest, 2000, Communicable diseases intelligence.

Update on childhood pneumococcal vaccination

P. McIntyre, G. Ridley, R. Menzies, 2008 .

Epidemiology of invasive meningococcal B disease in Australia, 1999–2015: priority populations for vaccination

J. McVernon, Monica Lahra, P. McIntyre, 2017, The Medical journal of Australia.

Meningococcal disease epidemiology in Australia 10 years after implementation of a national conjugate meningococcal C immunization programme

Monica Lahra, R. Booy, P. McIntyre, 2016, Epidemiology and Infection.

Clinical relevance of TLR2, TLR4, CD14 and FcγRIIA gene polymorphisms in Streptococcus pneumoniae infection

K. Marks, P. McIntyre, M. Wong, 2008, Immunology and cell biology.

Use of antibiotics and antifungal agents in herpetic gingivostomatitis.

P. McIntyre, P. Mcwhinney, 1991, The British journal of general practice : the journal of the Royal College of General Practitioners.

Summary of national surveillance data on vaccine preventable diseases in Australia, 2012-2015.

A. Dey, K. Macartney, P. McIntyre, 2019, Communicable diseases intelligence.

Persistence of immunity to conjugate and polysaccharide pneumococcal vaccines in frail, hospitalised older adults in long-term follow up.

C. Macintyre, P. McIntyre, I. Ridda, 2019, Vaccine.

A Randomized Clinical Trial of the Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine Compared to 23-Valent Polysaccharide Vaccine in Frail, Hospitalized Elderly

C. Macintyre, A. Hayen, R. Lindley, 2014, PloS one.

Tdap: a new option for pertussis booster vaccination of seniors

P. McIntyre, I. Ridda, 2012 .

Long-term impact of pneumococcal conjugate vaccines on invasive disease and pneumonia hospitalisations in Indigenous and non-Indigenous Australians.

V. Sintchenko, M. Kirk, A. Dey, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Reply to letter: Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia.

P. Beutels, A. Newall, P. McIntyre, 2019, Vaccine.

The role of timeliness in the cost-effectiveness of older adult vaccination: A case study of pneumococcal conjugate vaccine in Australia.

P. Beutels, C. Macintyre, J. Wood, 2018, Vaccine.

Determining the contribution of Streptococcus pneumoniae to community‐acquired pneumonia in Australia

P. McIntyre, R. Menzies, J. Yin, 2017, The Medical journal of Australia.

Cost-effectiveness of 13-valent pneumococcal conjugate vaccine (PCV13) in older Australians.

P. Beutels, C. Macintyre, J. Wood, 2017, Vaccine.

Long-term Impact of a “3 + 0” Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002–2014

C. Blyth, P. McIntyre, V. Krause, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Primary and booster immunization with a diphtheria, tetanus, acellular pertussis, hepatitis B (DTPa-HBV) and Haemophilus influenzae type b (Hib) vaccine administered separately or together is safe and immunogenic.

Peter McIntyre, H. Marshall, P. McIntyre, 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Australia's notifiable diseases status, 2005: annual report of the National Notifiable Diseases Surveillance System.

R. Owen, F. Kong, K. Hope, 2007, Communicable diseases intelligence quarterly report.

Australia's notifiable diseases status, 2004, annual report of the National Notifiable Diseases Surveillance System.

M. Kirk, S. Firestone, B. Hull, 2006, Communicable diseases intelligence quarterly report.

Long-term Vaccine Impact on Invasive Pneumococcal Disease Among Children With Significant Comorbidities in a Large Australian Birth Cohort.

Bette C Liu, P. McIntyre, H. Gidding, 2019, The Pediatric infectious disease journal.

Vaccination for the paediatrician

N. Wood, P. McIntyre, M. Wong, 2006, Journal of paediatrics and child health.

P. McIntyre, H. Gidding, F. Beard, 2005, Archives of Disease in Childhood.

Impact of pneumococcal polysaccharide vaccine in people aged 65 years or older

P. McIntyre, V. Krause, R. Menzies, 2014, The Medical journal of Australia.

Assessing the Evidence for Maternal Pertussis Immunization: A Report From the Bill & Melinda Gates Foundation Symposium on Pertussis Infant Disease Burden in Low- and Lower-Middle-Income Countries

K. O'Brien, P. van Damme, K. Klugman, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

High levels of antibody in adults three years after vaccination with a reduced antigen content diphtheria-tetanus-acellular pertussis vaccine.

P. McIntyre, M. Burgess, L. Schuerman, 2004, Vaccine.

Influenza and pneumococcal vaccine coverage among a random sample of hospitalised persons aged 65 years or more, Victoria.

H. Kelly, S. Skull, P. McIntyre, 2005, Communicable diseases intelligence quarterly report.

SEVERE PERTUSSIS IN INFANTS: ESTIMATED IMPACT OF FIRST VACCINE DOSE AT 6 VERSUS 8 WEEKS IN AUSTRALIA

M. Clements, H. Quinn, P. McIntyre, 2011, The Pediatric infectious disease journal.

Pneumococcal vaccines: past, present and future

P. McIntyre, C. Chiu, 2013 .

General practice encounters following seasonal influenza vaccination as a proxy measure of early-onset adverse events.

A. Dey, P. McIntyre, R. Menzies, 2014, Vaccine.

Influenza Vaccine Safety in Children Less Than 5 Years Old: The 2010 and 2011 Experience in Australia

N. Wood, V. Sheppeard, P. McIntyre, 2012, The Pediatric infectious disease journal.

Long term population impact of seven-valent pneumococcal conjugate vaccine with a "3+0″ schedule-How do "2+1″ and "3+1″ schedules compare?

H. Seale, P. McIntyre, M. Ferson, 2015, Vaccine.

Differing serologic responses to an haemophilus influenzae type b polysaccharide-neisseria meningitidis outer membrane protein conjugate (PRP-OMPC) vaccine in australian aboriginal and caucasian infants - implications for disease epidemiology.

D. Isaacs, P. McIntyre, S. Guthridge, 2000, Vaccine.

Vaccines against invasive Haemophilus influenzae type b disease

P. McIntyre, 1994, Journal of paediatrics and child health.

Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes.

S. Ladhani, R. Dagan, M. Ramsay, 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

The Australian Measles Control Campaign, 1998.

B. Hull, S. Lambert, P. McIntyre, 2001, Bulletin of the World Health Organization.

The Australian Measles Control Campaign , 1998 V

B. Hull, S. Lambert, P. McIntyre, 2001 .

Vaccine preventable diseases and vaccination coverage in Australia, 1993-1998.

B. Hull, S. Torvaldsen, P. McIntyre, 2000, Communicable diseases intelligence.

Better colonisation of newly emerged Bordetella pertussis in the co-infection mouse model study.

V. Sintchenko, H. Marshall, C. Tay, 2016, Vaccine.

Geographic differences in bacterial meningitis: Less may be as interesting as more

P. McIntyre, 1998, Journal of paediatrics and child health.

Childhood invasive haemophilus influenzae disease in the Sydney Region : epidemiology, public health importance and prevention

P. McIntyre, 1994 .

Using linked birth, notification, hospital and mortality data to examine false-positive meningococcal disease reporting and adjust disease incidence estimates for children in New South Wales, Australia

P. McIntyre, Louisa R Jorm, A. Gibson, 2015, Epidemiology and Infection.

Increased Population Prevalence of Low Pertussis Toxin Antibody Levels in Young Children Preceding a Record Pertussis Epidemic in Australia

J. McVernon, G. Gilbert, H. Quinn, 2012, PloS one.

The cost-effectiveness of pneumococcal conjugate vaccination in Australia.

B. Sander, P. McIntyre, C. MacIntyre, 2004, Vaccine.

Observational methods in epidemiologic assessment of vaccine effectiveness.

S. Torvaldsen, P. McIntyre, 2002, Communicable diseases intelligence quarterly report.

Pertussis vaccines: past, present and future in Australia.

P. McIntyre, B. Harvey, J. Forrest, 1998, Communicable diseases intelligence.

The Measles Control Campaign and immunisation adverse events.

P. McIntyre, M. Burgess, T. Heath, 1998, Communicable diseases intelligence.

Th2-polarisation of cellular immune memory to neonatal pertussis vaccination.

P. Holt, H. Marshall, N. Wood, 2010, Vaccine.

Recurrence of extensive injection site reactions following DTPa or dTpa vaccine in children 4-6 years old.

M. Gold, H. Marshall, P. McIntyre, 2011, Vaccine.

Effectiveness of 7- and 13-Valent Pneumococcal Conjugate Vaccines in a Schedule Without a Booster Dose: A 10-Year Observational Study

H. Quinn, P. McIntyre, R. Menzies, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Predictors of Disease Severity in Children Hospitalized for Pertussis During an Epidemic

H. Marshall, M. Nissen, P. McIntyre, 2015, The Pediatric infectious disease journal.

Booster vaccination of adults with reduced-antigen-content diphtheria, Tetanus and pertussis vaccine: immunogenicity 5 years post-vaccination.

P. McIntyre, M. Burgess, L. Schuerman, 2009, Vaccine.

Survey of pertussis morbidity in adults in western Sydney

P. Thomas, P. McIntyre, Bin B Jalaludln, 2000, The Medical journal of Australia.

Supplementary report: Surveillance of adverse events following immunisation among children aged less than seven years in Australia, 1 January to 30 June 2011.

P. McIntyre, R. Menzies, K. Macartney, 2012, Communicable diseases intelligence quarterly report.

Trends in invasive Haemophilus influenzae type B disease in Australia, 1995-2005.

S. Deeks, P. McIntyre, Han Wang, 2008, Communicable diseases intelligence quarterly report.

Progress towards eliminating Hib in Australia: an evaluation of Haemophilus influenzae type b prevention in Australia, 1 July 1993 to 30 June 2000.

P. Horby, P. McIntyre, R. Gilmour, 2003, Communicable diseases intelligence quarterly report.

Vaccines for other neonatal infections: Vaccination strategies for the prevention of neonatal pertussis

P. McIntyre, 2004, Expert review of vaccines.

Pertussis re‐emerging: who is responsible?

P. McIntyre, M. Burgess, T. Heath, 1998, Australian and New Zealand journal of public health.

Immunogenicity and Safety of Monovalent Acellular Pertussis Vaccine at Birth

H. Marshall, N. Wood, P. McIntyre, 2018, JAMA pediatrics.

Acellular Pertussis Vaccine at Birth and One Month Induces Antibody Responses By Two Months of Age

H. Marshall, N. Wood, P. McIntyre, 2010, The Pediatric infectious disease journal.

National study of infants hospitalized with pertussis in the acellular vaccine era

E. Elliott, J. Massie, P. McIntyre, 2004, The Pediatric infectious disease journal.

Immunisation coverage annual report, 2015

A. Dey, B. Hull, J. Brotherton, 2019, Communicable diseases intelligence.

Immunisation coverage annual report, 2014.

A. Dey, B. Hull, J. Brotherton, 2017, Communicable diseases intelligence quarterly report.

Immunisation coverage annual report, 2013.

A. Dey, B. Hull, J. Brotherton, 2016, Communicable diseases intelligence quarterly report.

Immunisation coverage, 2012.

A. Dey, B. Hull, J. Brotherton, 2014, Communicable diseases intelligence quarterly report.

Immunisation coverage annual report, 2011.

A. Dey, B. Hull, J. Brotherton, 2013, Communicable diseases intelligence quarterly report.

Annual immunisation coverage report, 2010.

A. Dey, B. Hull, P. McIntyre, 2013, Communicable diseases intelligence quarterly report.

Immunisation Coverage Annual Report 2019.

A. Dey, B. Hull, P. McIntyre, 2021, Communicable diseases intelligence.

The seroepidemiology of pertussis in Australia during an epidemic period

P. McIntyre, C. MacIntyre, A. Giammanco, 2006, Epidemiology and Infection.

Vaccine-associated paralytic poliomyelitis.

P. McIntyre, M. Burgess, M. Burgess, 1999, Communicable diseases intelligence.

Occult pneumococcal bacteraemia and febrile convulsions.

P. McIntyre, F. Harris, R. Kennedy, 1983, British medical journal.

Assessing the impact of the 13 valent pneumococcal vaccine on childhood empyema in Australia

H. Marshall, C. Wainwright, G. Gilbert, 2021, Thorax.

Australia's notifiable diseases status, 1998. Annual report of the National Notifiable Diseases Surveillance System.

P. McIntyre, E. O'Brien, L. Roberts, 1999, Communicable diseases intelligence.

Invasive Haemophilus influenzae type b disease in Australia: the beginning of the end?

Peter McIntyre, P. McIntyre, 1992, The Medical journal of Australia.

Lower immunity to poliomyelitis viruses in Australian young adults not eligible for inactivated polio vaccine.

A. Dey, H. Quinn, D. Dwyer, 2020, Vaccine.

The seroepidemiology of pertussis in NSW: fluctuating immunity profiles related to changes in vaccination schedules.

H. Quinn, P. McIntyre, R. Menzies, 2011, New South Wales public health bulletin.

Transiently increased IgE responses in infants and pre-schoolers receiving only acellular Diphtheria-Pertussis-Tetanus (DTaP) vaccines compared to those initially receiving at least one dose of cellular vaccine (DTwP) - Immunological curiosity or canary in the mine?

P. Sly, J. Carapetis, P. Holt, 2016, Vaccine.

Summary of National Surveillance Data on Vaccine Preventable Diseases in Australia, 2008-2011.

A. Dey, S. Knox, P. McIntyre, 2016, Communicable diseases intelligence quarterly report.

Acute flaccid myelitis - has it gone unrecognised in Australian children?

E. Elliott, P. McIntyre, B. Thorley, 2020, Communicable diseases intelligence.

Community-based estimates of incidence and risk factors for childhood pneumonia in Western Sydney

Peter McIntyre, P. McIntyre, C. MacIntyre, 2003, Epidemiology and Infection.

Rotavirus gastroenteritis: impact on young children, their families and the health care system

P. McIntyre, M. Burgess, M. Ferson, 1997, The Medical journal of Australia.

Australian vaccine preventable disease epidemiological review series: Influenza 2006 to 2015.

K. Macartney, P. McIntyre, F. Beard, 2016, Communicable diseases intelligence quarterly report.

Population-based seroprevalence of Neisseria meningitidis serogroup C capsular antibody before the introduction of conjugate vaccine, in Australia.

C. Macintyre, P. McIntyre, H. Gidding, 2007, Vaccine.

TREATMENT OF CONGENITAL TOXOPLASMOSIS

Christopher B Wilson, P. McIntyre, 1990, The Pediatric infectious disease journal.

BRASILIAN PURPURIC FEVER IN CENTRAL AUSTRALIA

P. McIntyre, G. Wheaton, J. Erlich, 1987, The Lancet.

Levels of pneumococcal conjugate vaccine coverage and indirect protection against invasive pneumococcal disease and pneumonia hospitalisations in Australia: An observational study

K. Mulholland, C. Nguyen, C. Blyth, 2021, PLoS medicine.

Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial

M. Chatfield, P. Morris, J. Carapetis, 2021, Vaccine: X.

Extending Antenatal Pertussis Immunization to Second Trimester or At-Birth Pertussis Immunization of Premature Infants?-Reply.

N. Wood, P. McIntyre, T. Nolan, 2019, JAMA pediatrics.

Genetically modified pertussis toxin: a quantum leap?

K. Edwards, P. McIntyre, 2018, The Lancet. Infectious diseases.

Evaluation of impact of 23 valent pneumococcal polysaccharide vaccine following 7 valent pneumococcal conjugate vaccine in Australian Indigenous children.

D. Lehmann, P. McIntyre, V. Krause, 2015, Vaccine.

The emergence of resistant pneumococcal meningitis—implications for empiric therapy

C. Mellis, P. McIntyre, P. McMaster, 2002, Archives of disease in childhood.

The relationship between pertussis symptomatology, incidence and serology in adolescents.

P. McIntyre, L. Heron, C. MacIntyre, 2008, Vaccine.

Cough symptoms in children aged 5–14 years in Sydney, Australia: non‐specific cough or unrecognized pertussis?

S. Torvaldsen, P. McIntyre, C. MacIntyre, 2005, Respirology.

A boarding school outbreak of pertussis in adolescents: value of laboratory diagnostic methods

P. Horby, M. Staff, P. McIntyre, 2004, Epidemiology and Infection.

The Impact of Pneumococcal Conjugate Vaccine on Rates of Myringotomy With Ventilation Tube Insertion in Australia

S. Deeks, P. McIntyre, R. Menzies, 2009, The Pediatric infectious disease journal.

A population based study of the impact of corticosteroid therapy and delayed diagnosis on the outcome of childhood pneumococcal meningitis

Peter McIntyre, P. McIntyre, C. MacIntyre, 2005, Archives of Disease in Childhood.

Immunogenicity of the reduced-antigen-content dTpa vaccine (Boostrix(®)) in adults 55 years of age and over: a sub-analysis of four trials.

P. van Damme, S. Kuriyakose, P. McIntyre, 2011, Vaccine.

Pertussis antibody levels in infants immunized with an acellular pertussis component vaccine, measured using whole‐cell pertussis ELISA

P. McIntyre, P. Devine, A. Kakakios, 2000, Immunology and cell biology.

Corticosteroids for acute bacterial meningitis.

D. van de Beek, P. McIntyre, K. Prasad, 2007, The Cochrane database of systematic reviews.

Population-Level Herd Protection of Males From a Female Human Papillomavirus Vaccination Program: Evidence from Australian Serosurveillance

H. Quinn, Alexis J Pillsbury, J. Brotherton, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Dexamethasone treatment for acute bacterial meningitis: how strong is the evidence for routine use?

P. McIntyre, 1996, Journal of neurology, neurosurgery, and psychiatry.

Intussusception After Monovalent Human Rotavirus Vaccine in Australia: Severity and Comparison of Using Healthcare Database Records Versus Case Confirmation to Assess Risk

A. Dey, H. Quinn, N. Wood, 2014, The Pediatric infectious disease journal.

Timeliness and factors associated with rotavirus vaccine uptake among Australian Aboriginal and non-Aboriginal children: A record linkage cohort study.

Bette C Liu, N. de Klerk, C. Blyth, 2019, Vaccine.

The Australian Childhood Immunisation Register-A model for universal immunisation registers?

S. Deeks, B. Hull, P. McIntyre, 2009, Vaccine.

Evaluation of Combination Measles-Mumps-Rubella-Varicella Vaccine Introduction in Australia

M. Gold, A. Dey, B. Hull, 2017, JAMA pediatrics.

Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months old.

R. Karron, B. Murphy, William Rodriguez, 2004, The Journal of infectious diseases.

‘Links2HealthierBubs’ cohort study: protocol for a record linkage study on the safety, uptake and effectiveness of influenza and pertussis vaccines among pregnant Australian women

S. Omer, N. de Klerk, D. Mak, 2019, BMJ Open.

Impact of pneumococcal polysaccharide vaccine in people aged 65 years or older

P. McIntyre, V. Krause, R. Menzies, 2014, The Medical journal of Australia.

Immunisation coverage in Australia corrected for under‐reporting to the Australian Childhood Immunisation Register

B. Hull, P. McIntyre, G. Lawrence, 2003, Australian and New Zealand journal of public health.

Stenotrophomonas maltophilia and lawn mower injuries in children.

A. Daley, P. McIntyre, 2000, The Journal of trauma.

Typhoid fever in children: diagnostic and therapeutic difficulties.

J. Morris, P. McIntyre, M. Stormon, 1997, The Pediatric infectious disease journal.

Australia's national Q fever vaccination program.

P. McIntyre, G. Lawrence, H. Gidding, 2009, Vaccine.

Pneumocystis carinii pneumonia: Pitfalls of prophylaxis

P. McIntyre, P. van Asperen, Rjh Massie, 1998, Journal of Paediatrics and Child Health.

Acyclovir for the prevention and treatment of varicella zoster in children, adolescents and pregnancy

D. Isaacs, P. McIntyre, K. Grimwood, 1996, Journal of paediatrics and child health.

Position Paper: Chemoprophylaxis for Haemophilus and meningococcal infections

D. Isaacs, P. McIntyre, K. Grimwood, 1994 .

PERTUSSIS VACCINE EFFECTIVENESS AFTER MASS IMMUNIZATION OF HIGH SCHOOL STUDENTS IN AUSTRALIA

H. Quinn, P. McIntyre, C. Rank, 2009, The Pediatric infectious disease journal.

Cellulitis in childhood invasive pneumococcal disease: A population‐based study

P. McIntyre, J. Gubbay, R. Gilmour, 2006, Journal of paediatrics and child health.

Varicella vaccine effectiveness over 10 years in Australia; moderate protection from 1-dose program.

E. Elliott, H. Marshall, H. Quinn, 2019, The Journal of infection.

Q fever seroprevalence in Australia suggests one in twenty people have been exposed

D. Durrheim, H. Quinn, N. Wood, 2020, Epidemiology and Infection.

Sub-optimal protection against past hepatitis B virus infection where subtype mismatch exists between vaccine and circulating viral genotype in northern Australia.

S. Tong, S. Locarnini, N. Wood, 2018, Vaccine.

Vaccine preventable diseases and vaccination policy for indigenous populations.

Peter McIntyre, P. McIntyre, R. Menzies, 2006, Epidemiologic reviews.

Vaccine preventable diseases and vaccination coverage in Australia, 2003 to 2005.

B. Hull, R. MacIntyre, H. Quinn, 2007, Communicable diseases intelligence quarterly report.

Epiglottitis in Sydney before and after the introduction of vaccination against Haemophilus influenzae type b disease

N. Wood, P. McIntyre, R. Menzies, 2005, Internal medicine journal.

Annual report: surveillance of adverse events following immunisation in Australia, 2008.

M. Gold, P. McIntyre, R. Menzies, 2009, Communicable diseases intelligence quarterly report.

Annual report: surveillance of adverse events following immunisation in Australia, 2004.

D. Isaacs, P. McIntyre, G. Lawrence, 2010, Communicable diseases intelligence quarterly report.

Neonatal Immunization: Rationale, Current State, and Future Prospects

O. Levy, D. Goldblatt, P. McIntyre, 2018, Front. Immunol..

Vaccine preventable diseases in Australia, 2005 to 2007.

Andrew Jardine, Robert Booy, Kristine Macartney, 2010, Communicable diseases intelligence quarterly report.

Pertussis: Biology, epidemiology and prevention.

K. Mills, S. Halperin, S. Plotkin, 2016, Vaccine.

Reasons for incomplete immunisation among Australian children. A national survey of parents.

B. Hull, P. McIntyre, G. Lawrence, 2004, Australian family physician.

The impact of vaccination against invasive Haemophilus influenzae type b disease in the Sydney region

T. Chey, P. McIntyre, Wayne T Smith, 1995, The Medical journal of Australia.

Lumbar puncture in suspected neonatal sepsis

D. Isaacs, P. McIntyre, 1995, Journal of paediatrics and child health.

COVID-19 vaccine strategies must focus on severe disease and global equity

S. Madhi, Rakesh Aggarwal, S. Kochhar, 2021, The Lancet.

The changing and dynamic epidemiology of meningococcal disease.

L. Harrison, B. Greenwood, S. Ladhani, 2012, Vaccine.

Pertussis: review of epidemiology, diagnosis, management and prevention.

Nicholas Wood, Peter McIntyre, N. Wood, 2008, Paediatric respiratory reviews.

Australian vaccine preventable disease epidemiological review series: measles 2000-2011.

A. Dey, S. Davis, May Chiew, 2015, Communicable diseases intelligence quarterly report.

Immunisation coverage annual report, 2008.

A. Dey, B. Hull, P. McIntyre, 2010, Communicable diseases intelligence quarterly report.

Immunisation coverage annual report, 2007.

S. Deeks, B. Hull, P. McIntyre, 2009, Communicable diseases intelligence quarterly report.

Timeliness of childhood immunisation in Australia.

B. Hull, P. McIntyre, 2006, Vaccine.

What do we know about 7vPCV coverage in Aboriginal and Torres Strait Islander children?

B. Hull, P. McIntyre, 2004, Communicable diseases intelligence quarterly report.

Estimating immunisation coverage: is the 'third dose assumption' still valid?

C. Macintyre, B. Hull, P. McIntyre, 2003, Communicable diseases intelligence quarterly report.

Measuring immunisation coverage in Australia. A review of the Australian Childhood Immunisation Register.

B. Hull, P. McIntyre, Peter Mcintyre, 1999, Australian family physician.

HPV genotype prevalence in Australian women undergoing routine cervical screening by cytology status prior to implementation of an HPV vaccination program.

S. Garland, J. Condon, S. Tabrizi, 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Anaphylaxis following quadrivalent human papillomavirus vaccination

M. Gold, A. Kemp, J. Brotherton, 2008, Canadian Medical Association Journal.

Ulcerative lesion of the nasal bridge in a five-month-old infant.

D. Isaacs, A. Daley, P. McIntyre, 1999, The Pediatric Infectious Disease Journal.

Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988.

C. Berkey, G. Kanra, U. Schaad, 1997, JAMA.

Adjunctive dexamethasone in meningitis: does value depend on clinical setting?

P. McIntyre, 2010, The Lancet Neurology.

Vaccine Preventable Diseases and Vaccination Coverage in Aboriginal and Torres Strait Islander People, Australia, 2011–2015

A. Dey, B. Hull, K. Macartney, 2019, Communicable diseases intelligence.

Models of strategies for control of rubella and congenital rubella syndrome-a 40 year experience from Australia.

C. Macintyre, J. Wood, P. McIntyre, 2013, Vaccine.

Current epidemiology of rubella and congenital rubella syndrome in Australia: progress towards elimination.

C. Macintyre, G. Gilbert, H. Quinn, 2012, Vaccine.

Vaccine preventable diseases and vaccination coverage in Australia 2001 to 2002.

B. Hull, R. MacIntyre, N. Wood, 2004, Communicable diseases intelligence quarterly report.

Australian rubella serosurvey 2012-2013: On track for elimination?

A. Dey, D. Dwyer, J. Wood, 2018, Vaccine.

A history of adolescent school based vaccination in Australia.

H. Quinn, P. McIntyre, R. Menzies, 2013, Communicable diseases intelligence quarterly report.

Changes in Patterns of Hospitalized Children With Varicella and of Associated Varicella Genotypes After Introduction of Varicella Vaccine in Australia

Y. Zurynski, E. Elliott, M. Gold, 2013, The Pediatric infectious disease journal.

Occult pneumococcal bacteraemia and febrile convulsions.

P. McIntyre, F. Harris, 1983, British medical journal.

Evaluation of a protocol for selective empiric treatment of fever without localising signs

J. Ryan, P. McIntyre, G. Browne, 1997, Archives of disease in childhood.

Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program

S. Garland, J. Condon, S. Tabrizi, 2011, BMC medicine.

UNSUSPECTED BACTERIAL INFECTION IN FEBRILE CONVULSION

P. McIntyre, J. Vance, S. Gray, 1990 .

SARS-CoV-2 Vaccines: Where Are We Now?

P. McIntyre, C. MacIntyre, M. Nelson, 2021, The Journal of Allergy and Clinical Immunology: In Practice.

Surveillance of adverse events following immunisation: Australia 2002 to 2003.

D. Isaacs, P. McIntyre, G. Lawrence, 2004, Communicable diseases intelligence quarterly report.

Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia.

C. Macintyre, M. Esser, H. Quinn, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Control of varicella in the post-vaccination era in Australia: a model-based assessment of catch-up and infant vaccination strategies for the future

C. Macintyre, J. Wood, A. Newall, 2014, Epidemiology and Infection.

Elimination of endemic measles transmission in Australia.

H. Kelly, A. Heywood, P. McIntyre, 2009, Bulletin of the World Health Organization.

Sustained measles elimination in Australia and priorities for long term maintenance.

H. Kelly, J. Wood, S. Lambert, 2007, Vaccine.

National study of adverse reactions after vaccination with bacille Calmette-Guérin.

M. Gold, R. Stapledon, P. McIntyre, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Global Childhood Deaths From Pertussis: A Historical Review

Peter McIntyre, P. McIntyre, G. Khandaker, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The NSW Immunisation Strategy 2008-2011: how are we doing?

D. Durrheim, P. McIntyre, S. Campbell-Lloyd, 2010, New South Wales public health bulletin.

Epidemiology of invasive pneumococcal disease in urban New South Wales, 1997–1999

C. Mellis, P. McIntyre, G. Gilbert, 2000, The Medical journal of Australia.

Vaccine preventable diseases and vaccination coverage in Australia, 1993-1998.

J. Amin, B. Hull, S. Torvaldsen, 2000, Communicable diseases intelligence.

Polio – The old foe and new challenges: An update for clinicians

D. Isaacs, E. Elliott, N. Dinsmore, 2020, Journal of paediatrics and child health.

Pneumococcal disease in Australia.

P. McIntyre, M. Burgess, J. Forrest, 2000, Communicable diseases intelligence.

Multiple liver abscesses in Crohn's disease.

P. McIntyre, S. Manjunatha, A. Lynn, 1992, British journal of hospital medicine.

The importance of pertussis in older adults: a growing case for reviewing vaccination strategy in the elderly.

P. McIntyre, I. Ridda, C. Raina MacIntyre, 2012, Vaccine.

Adolescent school-based vaccination in Australia.

H. Quinn, P. McIntyre, S. Campbell-Lloyd, 2013, Communicable diseases intelligence quarterly report.

Economic evaluations of implemented vaccination programmes: key methodological challenges in retrospective analyses.

P. Beutels, J. Wood, A. Newall, 2014, Vaccine.

Prevention of serious bacterial infection in children with nephrotic syndrome

P. McIntyre, J. Craig, 1998, Journal of paediatrics and child health.

Annual report: surveillance of adverse events following immunisation in Australia, 2010.

P. McIntyre, R. Menzies, K. Macartney, 2011, Communicable diseases intelligence quarterly report.

Defining long-term drivers of pertussis resurgence, and optimal vaccine control strategies.

J. McVernon, J. McCaw, P. McIntyre, 2015, Vaccine.

Antibody persistence six years after two doses of combined hepatitis A and B vaccine.

M. Hellard, P. McIntyre, M. Burgess, 2010, Vaccine.

The "how" of polymerase chain reaction testing for Bordetella pertussis depends on the "why".

V. Sintchenko, P. McIntyre, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Influence of Population Demography and Immunization History on the Impact of an Antenatal Pertussis Program

N. Geard, J. McVernon, P. McIntyre, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Measles vaccine, inflammatory bowel disease and pervasive developmental disorder: is there cause for concern?

P. McIntyre, J. Amin, T. Heath, 1998, Communicable diseases intelligence.

Does universal hepatitis B vaccination at birth have a negative impact on breastfeeding

N. Wood, P. McIntyre, 2004 .

MMR, autism and inflammatory bowel disease: responding to patient concerns using an evidence-based framework.

P. McIntyre, C. MacIntyre, 2001, The Medical journal of Australia.

Fall in genital warts diagnoses in the general and indigenous Australian population following implementation of a national human papillomavirus vaccination program: analysis of routinely collected national hospital data.

Bette C Liu, A. Dey, K. Canfell, 2015, The Journal of infectious diseases.

10-Valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine (PHiD-CV10) versus 13-valent pneumococcal conjugate vaccine (PCV13) as a booster dose to broaden and strengthen protection from otitis media (PREVIX_BOOST) in Australian Aboriginal children: study protocol for a randomised

M. Chatfield, P. Morris, J. Carapetis, 2020, BMJ Open.

Clinical epidemiology and predictors of outcome in children hospitalised with influenza A(H1N1)pdm09 in 2009: a prospective national study

Y. Zurynski, E. Elliott, M. Gold, 2014, Influenza and other respiratory viruses.

Pertussis epidemiology in Australia over the decade 1995-2005--trends by region and age group.

H. Quinn, P. McIntyre, Helen E Quinn, 2007, Communicable diseases intelligence quarterly report.

Effect of the preschool pertussis booster on national notifications of disease in Australia

S. Torvaldsen, P. McIntyre, 2003, The Pediatric infectious disease journal.

Pneumonia in Elderly Australians: Reduction in Presumptive Pneumococcal Hospitalizations but No Change in All-Cause Pneumonia Hospitalizations Following 7-Valent Pneumococcal Conjugate Vaccination.

P. McIntyre, R. Menzies, A. Jardine, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Declining measles antibodies in the era of elimination: Australia's experience.

H. Quinn, D. Dwyer, P. McIntyre, 2018, Vaccine.

Pertussis in older adults: prospective study of risk factors and morbidity.

Bette C Liu, J. Kaldor, E. Banks, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The utility of seroepidemiology for tracking trends in pertussis infection

H. Quinn, J. Brotherton, P. McIntyre, 2009, Epidemiology and Infection.

Pertussis in early infancy: disease burden and preventive strategies

Nicholas Wood, Peter McIntyre, N. Wood, 2009, Current opinion in infectious diseases.

Immunisation at the crossroads: 9th National Immunisation/1st Asia–Pacific Vaccine Preventable Diseases Conference

P. McIntyre, H. Kelly, E Kim Mulholland, 2005, Medical Journal of Australia.

Pertussis in infants: Preventing deaths and hospitalisations in the very young

Nicholas Wood, Peter McIntyre, E. Elliott, 2008, Journal of paediatrics and child health.

Differences in attitudes, beliefs and knowledge of hospital health care workers and community doctors to vaccination of older people.

C. Macintyre, P. McIntyre, I. Ridda, 2008, Vaccine.

Temporal trends in circulating Bordetella pertussis strains in Australia

F. Mooi, P. McIntyre, K. Heuvelman, 2004, Epidemiology and Infection.

Effectiveness of pertussis vaccination in New South Wales, Australia, 1996–1998

J. Simpson, S. Torvaldsen, P. McIntyre, 2004, European Journal of Epidemiology.

Pertussis vaccination strategies for neonates--an exploratory cost-effectiveness analysis.

P. Scuffham, P. McIntyre, P. Mcintyre, 2004, Vaccine.

Pertussis vaccination in a cohort of older Australian adults following a cocooning vaccination program.

J. Kaldor, C. Macintyre, E. Banks, 2018, Vaccine.

Diagnostic testing and discharge coding for whooping cough in a children's hospital

P. McIntyre, R. Menzies, G. Bonacruz-Kazzi, 2003, Journal of paediatrics and child health.

Parent and general practitioner preferences for infant immunisation. Reactogenicity or multiple injections?

P. McIntyre, M. Bartlett, M. Burgess, 1999, Australian family physician.

Effectiveness of pneumococcal conjugate vaccine against hospital admissions for pneumonia in Australian children: a retrospective, population-based, record-linked cohort study.

Bette C Liu, N. de Klerk, C. Blyth, 2019, The Lancet. Child & adolescent health.

Immunisation: reducing health inequality for Indigenous Australians

P. McIntyre, R. Menzies, 2005, The Medical journal of Australia.

Effectiveness of a publicly funded pneumococcal vaccination program against invasive pneumococcal disease among the elderly in Victoria, Australia.

P. McIntyre, R. Andrews, G. Hogg, 2004, Vaccine.

PhD thesis opposing immunisation: Failure of academic rigour with real-world consequences.

J. Leask, P. McIntyre, M. Burgess, 2019, Vaccine.

Australia's health 2002 : the eighth biennial report of the Australian Institute of Health and Welfare

P. Horby, J. Kaldor, H. Britt, 2002 .

Measles control in Australia. Report of the Measles Control in Australia Workshop, 5 November 1997.

P. McIntyre, M. Burgess, J. Forrest, 1998, Communicable diseases intelligence.

How accurately does the Australian Immunisation Register identify children overdue for vaccine doses? A national cross-sectional study.

A. Dey, B. Hull, K. Macartney, 2022, Communicable diseases intelligence.

Is low immunisation coverage in inner urban areas of Australia due to low uptake or poor notification?

B. Hull, P. McIntyre, G. Lawrence, 2003, Australian family physician.

Annual Immunisation Coverage Report 2016.

A. Dey, B. Hull, J. Brotherton, 2019, Communicable diseases intelligence.

Agreement between diagnoses of otitis media by audiologists and otolaryngologists in Aboriginal Australian children

E. Banks, H. Coates, P. McIntyre, 2018, The Medical journal of Australia.

Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.

P. McIntyre, R. Menzies, C. Lowbridge, 2013, Communicable diseases intelligence quarterly report.

Factors associated with pneumococcal immunisation among hospitalised elderly persons: a survey of patient's perception, attitude, and knowledge.

C. Macintyre, P. McIntyre, I. Ridda, 2008, Vaccine.

Annual report: surveillance of adverse events following immunisation in Australia, 2009.

M. Gold, P. McIntyre, R. Menzies, 2010, Communicable diseases intelligence quarterly report.

An economic analysis of alternatives for childhood immunisation against Haemophilus influenzae type b disease.

S. Leeder, P. McIntyre, J. Hall, 2010, Australian journal of public health.

Effectiveness of 7-Valent Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease in Medically At-Risk Children in Australia: A Record Linkage Study

Bette C Liu, D. Randall, A. Newall, 2022, Journal of the Pediatric Infectious Diseases Society.

Influenza Epidemiology, Vaccine Coverage and Vaccine Effectiveness in Children Admitted to Sentinel Australian Hospitals in 2017: Results from the PAEDS-FluCAN Collaboration

P. Kelly, T. Kotsimbos, A. Cheng, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparison of influenza vaccination coverage between immigrant and Australian-born adults.

Bette C Liu, C. Macintyre, E. Banks, 2016, Vaccine.

No evidence of increasing Haemophilus influenzae non-b infection in Australian Aboriginal children

P. McIntyre, R. Menzies, P. Markey, 2013, International journal of circumpolar health.

Australian mumps serosurvey 2012-2013: any cause for concern?

A. Dey, H. Quinn, D. Dwyer, 2020, Communicable diseases intelligence.

Factors associated with influenza vaccination in middle and older aged Australian adults according to eligibility for the national vaccination program.

Bette C Liu, J. Kaldor, C. Macintyre, 2015, Vaccine.

Risk factors for pertussis hospitalizations in Australians aged 45 years and over: A population based nested case-control study.

Bette C Liu, C. Macintyre, E. Banks, 2015, Vaccine.

Reducing Fatal Childhood Infections

P. McIntyre, 1991 .

Evaluation of Two Enzyme Immunoassays for Detection of Immunoglobulin G Antibodies to Mumps Virus

P. McIntyre, H. Gidding, G. Gilbert, 2006, Clinical and Vaccine Immunology.

Impact of the Australian Measles Control Campaign on immunity to measles and rubella

P. McIntyre, H. Gidding, G. Gilbert, 2001, Epidemiology and Infection.

Corticosteroids for acute bacterial meningitis.

M. Brouwer, D. van de Beek, P. McIntyre, 2013, The Cochrane database of systematic reviews.

Epidemiology of severe hepatitis A in Indigenous Australian children

D. Isaacs, B. Hull, P. McIntyre, 2007, Journal of paediatrics and child health.

Assessing the effect of meningitis prevention and treatment.

P. McIntyre, T. Snelling, 2014, The Lancet. Infectious diseases.

The association of respiratory viruses, temperature, and other climatic parameters with the incidence of invasive pneumococcal disease in Sydney, Australia.

P. McIntyre, M. Ferson, R. Menzies, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Compliance with three simultaneous vaccinations due at the one visit at 12 months of age in Australia.

B. Hull, P. McIntyre, 2007, Communicable diseases intelligence quarterly report.

Influenza vaccination coverage in a population-based cohort of Australian-born Aboriginal and non-Indigenous older adults

Bette C Liu, J. Kaldor, C. Macintyre, 2019, Communicable diseases intelligence.

A mathematical model to measure the impact of the Measles Control Campaign on the potential for measles transmission in Australia.

N. Gay, B. Hull, P. McIntyre, 2002, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Association between body mass index and laboratory-confirmed influenza in middle aged and older adults: a prospective cohort study

C. Macintyre, Peter McIntyre, E. Banks, 2018, International Journal of Obesity.

Healthcare Resource Utilisation Associated with Herpes Zoster in a Prospective Cohort of Older Australian Adults

Bette C Liu, C. Macintyre, E. Banks, 2016, PloS one.

Antibodies to Mumps Virus for Detection of Immunoglobulin G Evaluation of Two Enzyme Immunoassays

P. McIntyre, H. Gidding, G. Gilbert, 2006 .

Whole cell pertussis vaccination and decreased risk of IgE-mediated food allergy: a nested case-control study.

P. Holt, D. Campbell, M. Gold, 2019, The journal of allergy and clinical immunology. In practice.

Human papillomavirus vaccine safety in Australia: experience to date and issues for surveillance.

M. Gold, P. McIntyre, 2010, Sexual health.

More data from Australia on sensitivity to HPV vaccine

A. Kemp, P. McIntyre, M. Burgess, 2009, BMJ : British Medical Journal.

Predicting localised measles outbreak potential in Australia.

C. Macintyre, A. Heywood, J. Wood, 2015, Vaccine.

Improving uptake of MMR vaccine

Peter McIntyre, J. Leask, P. McIntyre, 2008, BMJ : British Medical Journal.

Are general practice registrars prepared for immunisation? A cross sectional survey.

J. Leask, P. McIntyre, Alison Williams, 2004, Australian Family Physician.

Assessment of on-time vaccination coverage in population subgroups: A record linkage cohort study.

Bette C Liu, N. de Klerk, C. Blyth, 2018, Vaccine.

No Jab, No Pay and vaccine refusal in Australia: the jury is out

J. Leask, P. McIntyre, F. Beard, 2017, The Medical journal of Australia.

Pneumococcal conjugate vaccines PREVenar13 and SynflorIX in sequence or alone in high-risk Indigenous infants (PREV-IX_COMBO): protocol of a randomised controlled trial

Jonathan Carapetis, Peter McIntyre, P. Morris, 2015, BMJ Open.

Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.

P. McIntyre, R. Menzies, C. Chiu, 2008, Communicable diseases intelligence quarterly report.

Immunisation and pregnancy - who, what, when and why?

P. McIntyre, A. Regan, K. Wiley, 2017, Australian Prescriber.

Pertussis Disease and Antenatal Vaccine Effectiveness in Australian Children

E. Elliott, H. Marshall, C. Blyth, 2021, The Pediatric Infectious Disease Journal.

Diphtheria immunity in Australia: should we be concerned?

H. Quinn, P. McIntyre, R. Menzies, 2018, Infectious disorders drug targets.

Higher pertussis hospitalization rates in indigenous Australian infants, and delayed vaccination.

P. McIntyre, R. Menzies, Veronica Kolos, 2007, Vaccine.

Making influenza vaccination mandatory for health care workers: the views of NSW Health administrators and clinical leaders.

C. Helms, J. Leask, P. McIntyre, 2010, New South Wales public health bulletin.

Otitis media outcomes of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine and 13-valent pneumococcal conjugate vaccine schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial

M. Chatfield, P. Morris, E. Mulholland, 2021, BMC Pediatrics.

Estimating Vaccine Coverage from Serial Trivariate Serologic Data in the Presence of Waning Immunity

N. Hens, N. Goeyvaerts, C. Macintyre, 2015, Epidemiology.

Trends in genital warts by socioeconomic status after the introduction of the national HPV vaccination program in Australia: analysis of national hospital data

Bette C Liu, A. Dey, K. Canfell, 2015, BMC Infectious Diseases.

Risk factors for herpes zoster in a large cohort of unvaccinated older adults: a prospective cohort study

J. Kaldor, C. Macintyre, Peter McIntyre, 2015, Epidemiology and Infection.

Tetanus immunity and epidemiology in Australia, 1993-2010.

H. Quinn, P. McIntyre, R. Menzies, 2018, Infectious disorders drug targets.

Genomic dissection of Australian Bordetella pertussis isolates from the 2008-2012 epidemic.

V. Sintchenko, H. Marshall, S. Octavia, 2016, The Journal of infection.

Changing Patterns of Pertussis in a Children's Hospital in the Polymerase Chain Reaction Diagnostic Era.

H. Quinn, N. Wood, P. McIntyre, 2016, The Journal of pediatrics.

Pertussis vaccination and allergic illness in Australian children

B. Toelle, G. Marks, N. Wood, 2020, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

1st International Neonatal and Maternal Immunization Symposium

N. Wood, P. McIntyre, 2010 .

Annual report: Surveillance of adverse events following immunisation in Australia, 2005.

D. Isaacs, P. McIntyre, G. Lawrence, 2006, Communicable diseases intelligence quarterly report.

Effectiveness of acellular pertussis vaccine in older adults: nested matched case-control study.

Bette C Liu, A. Hayen, H. Quinn, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of Childhood Pneumococcal Conjugate Vaccine on Nonnotified Clinically Suspected Invasive Pneumococcal Disease in Australia.

Bette C Liu, P. McIntyre, H. Gidding, 2019, The Pediatric infectious disease journal.

Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia.

P. Beutels, C. Macintyre, J. Wood, 2018, Vaccine.

Vaccines for preventing varicella in children and adults

P. McIntyre, B. Law, L. Coole, 1999 .

COVID-19 vaccines – are we there yet?

K. Macartney, P. McIntyre, K. Flanagan, 2020, Australian prescriber.

High healthcare resource utilisation due to pertussis in Australian adults aged 65 years and over.

Bette C Liu, J. Wood, A. Newall, 2020, Vaccine.

Pertussis vaccine in pregnancy—first dose for every infant?

T. Clark, P. McIntyre, 2014, The Lancet.

Lack of pneumococcal carriage in the hospitalised elderly.

C. Macintyre, R. Lindley, P. McIntyre, 2010, Vaccine.

Estimating the burden of pertussis in young children on hospitals and emergency departments: a study using linked routinely collected data

P. McIntyre, Louisa R Jorm, L. McCallum, 2013, Epidemiology and Infection.

Annual report on surveillance of adverse events following immunisation in Australia, 2006.

M. Gold, P. McIntyre, G. Lawrence, 2007, Communicable diseases intelligence quarterly report.

Evaluation of immunisation coverage for Aboriginal and Torres Strait Islander children using the Australian Childhood Immunisation Register

B. Hull, P. McIntyre, Sophia Couzos, 2004, Australian and New Zealand journal of public health.

Long-Term Trends in Invasive Haemophilus influenzae Type b Disease among Indigenous Australian Children Following use of PRP-OMP and PRP-T Vaccines

P. McIntyre, R. Menzies, F. Beard, 2015, The Pediatric infectious disease journal.

Pneumonia hospitalisation and case-fatality rates in older Australians with and without risk factors for pneumococcal disease: implications for vaccine policy

C. Macintyre, J. Wood, A. Newall, 2019, Epidemiology and Infection.

Planning for human papillomavirus vaccines in Australia; report of a research group meeting.

J. Brotherton, P. McIntyre, 2004, Communicable diseases intelligence quarterly report.

Should dexamethasone be part of routine therapy of bacterial meningitis in industrialised countries?

P. McIntyre, 2005, Advances in experimental medicine and biology.

Estimating pneumococcal vaccine coverage among Australian Indigenous children and children with medically at-risk conditions using record linkage.

Bette C Liu, D. Randall, A. Newall, 2021, Vaccine.

Public opponents of vaccination: a case study.

J. Leask, P. McIntyre, 2003, Vaccine.

Epidemiology of invasive meningococcal B disease in Australia, 1999–2015: priority populations for vaccination

J. McVernon, Monica Lahra, P. McIntyre, 2017 .

Corticosteroids in acute bacterial meningitis.

D. van de Beek, P. McIntyre, K. Prasad, 2003, The Cochrane database of systematic reviews.

Surveillance and diagnostics

H. Quinn, P. McIntyre, S. Bolotin, 2018, Pertussis.

Clinical relevance of TLR2, TLR4, CD14 and FcγRIIA gene polymorphisms in Streptococcus pneumoniae infection

K. Marks, P. McIntyre, M. Wong, 2008, Immunology and cell biology.

Pertussis control: where to now?

P. McIntyre, T. Nolan, 2014, The Medical journal of Australia.

The changing and dynamic epidemiology of meningococcal disease.

L. Harrison, B. Greenwood, S. Ladhani, 2012, Vaccine.

Potential impacts of schedule changes, waning immunity and vaccine uptake on measles elimination in Australia.

A. Heywood, J. Wood, K. Macartney, 2009, Vaccine.

Australia's notifiable diseases status, 2005: annual report of the National Notifiable Diseases Surveillance System.

I. Barr, R. Owen, K. Hope, 2007, Communicable diseases intelligence quarterly report.

Influenza Vaccine Safety in Children Less Than 5 Years Old: The 2010 and 2011 Experience in Australia

N. Wood, V. Sheppeard, P. McIntyre, 2012, The Pediatric infectious disease journal.

Long term population impact of seven-valent pneumococcal conjugate vaccine with a "3+0″ schedule-How do "2+1″ and "3+1″ schedules compare?

H. Seale, P. McIntyre, M. Ferson, 2015, Vaccine.

HPV genotype prevalence in Australian women undergoing routine cervical screening by cytology status prior to implementation of an HPV vaccination program.

S. Garland, J. Condon, S. Tabrizi, 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Establishment of a surveillance system (utilising Midwifes Data Collection Systems) for monitoring the impact of hepatitis B vaccination on the population prevalence of chronic hepatitis B virus infection in Australia

J. Kaldor, H. Quinn, N. Wood, 2008, Australian and New Zealand journal of public health.

Australian vaccine preventable disease epidemiological review series: Influenza 2006 to 2015.

K. Macartney, P. McIntyre, F. Beard, 2016, Communicable diseases intelligence quarterly report.

Human papillomavirus vaccine safety in Australia: experience to date and issues for surveillance.

M. Gold, P. McIntyre, 2010, Sexual health.